Ceregene Advances Phase 2b CERE-120 (AAV2-neurturin) Trial in Parkinson... ( SAN DIEGO Feb. 3 2011 /- Ceregene Inc...)

Ceregene Advances Phase 2b CERE-120 (AAV2-neurturin) Trial in Parkinson's Disease

Date:2/3/2011

SAN DIEGO, Feb. 3, 2011 /PRNewswire/ -- Ceregene, Inc., a biopharmaceutical company, announced today that it is progressing with enrollment and dosing in its CERE-120 (AAV2-neurturin) Phase 2b multi-center, sham-surgery, double-blinded controlled trial in Parkinson's disease. This trial was initiated in October 2010 and all 11 centers across the United States are now actively enrolling patients. These sites are among the best movement disorders centers in the country and include Baylor College of Medicine (Houston, TX), Beth Israel Medical Center (New York, NY), Columbia University Medical Center (New York, NY), Duke University School of Medicine (Durham, NC), Emory University Hospital (Atlanta, GA), Mount Sinai Medical Center (New York, NY), Rush University Medical Center (Chicago, IL), Stanford University School of Medicine (Palo Alto, CA), University of Alabama (Birmingham, AL), University of California (San Francisco, CA) and University of Pennsylvania Hospital (Philadelphia, PA). To date, approximately 20 percent of the 52 subjects have undergone either CERE-120 administration or sham surgery, with many others enrolled and awaiting surgery. It is anticipated that enrollment will be completed near the end of June 2011.

"We appreciate the enthusiasm and support this trial has received from investigators at the study centers as well as from the Parkinson's community. We look forward to completing enrollment as efficiently and responsibly as possible," stated Jeffrey M. Ostrove, Ph.D., president and chief executive officer of Ceregene.

This Phase 2b trial was initiated following the successful dosing of six patients in a Phase 1 safety trial that evaluated, for the first time, the feasibility and safety of targeting the substantia nigra with CERE-120, as well as administering a larger dose than had been tested previously. The Phase 1 safety database currently reflects follow-up periods ranging from seven to 13 mo
'/>"/>

SOURCE Ceregene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related medicine technology :

1. Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinsons Disease
2. Ceregene Initiates a New Controlled Phase 2b Trial of CERE-120 for Parkinsons Disease
3. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
4. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
5. Avicena Scientific Collaborator Advances Program for Using Energy Enhancing Molecules to Treat Neuromuscular Diseases
6. Groundbreaking Study Proves Personalized Diet Based on Genetics Leads to Significant Advances in Long Term Weight Management and Blood Glucose Levels
7. Thermo Fisher Scientific Advances Gene-Silencing Technology for Life Sciences Research
8. Stem Cell Breakthrough Advances Science Without Ethical Landmines, Says Cardinal
9. Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs
10. MedImmune Advances Clinical Development of Antibody Targeting Interleukin-9 in Patients with Asthma
11. Transdel Pharmaceuticals Advances Lead Topical Pain Drug into Phase 3 Program

Post Your Comments:

(Date:6/17/2013)... June 17, 2013 Today BioSpace , the leading ... BioCapital Hotbed map campaign spotlighting the life sciences community ... , Delaware and Washington ... ) The BioCapital area continues to ... BioSpace.com average 21 applies each - a strong ...

(Date:6/17/2013)... , June 17, 2013 Actavis, Inc. (NYSE: ... Court has reversed the decision of the U.S. Court of ... Court,s ruling granting Actavis, motion to dismiss the Federal Trade ... Court,s reversal was the result of a decision by a ... "quick look" approach and adopted the traditional "rule of reason" ...

(Date:6/17/2013)... June 17, 2013 Royal Philips (NYSE: ... for its Iterative Model Reconstruction (IMR) technology, ... simultaneously bring enhanced benefits to clinicians and ... the International Society for Computed Tomography,s (ISCT) ... and include IMR,s ability to simultaneously deliver ...

Breaking Medicine Technology:Mid-Atlantic Biotech Leaders Featured On BioSpace Map 2 U.S. Supreme Court Reverses U.S. Court of Appeals Decision in FTC v. Actavis 2 U.S. Supreme Court Reverses U.S. Court of Appeals Decision in FTC v. Actavis 3 Philips IMR offers new capabilities to simultaneously reduce CT Radiation and enhance image quality 2 Philips IMR offers new capabilities to simultaneously reduce CT Radiation and enhance image quality 3

[0] Mid-Atlantic Biotech Leaders Featured On BioSpace Map [0] U.S. Supreme Court Reverses U.S. Court of Appeals Decision in FTC v. Actavis [0] Philips IMR offers new capabilities to simultaneously reduce CT Radiation and enhance image quality

... MORRISTOWN, N.J., Jan. 3, 2012 Actavis Group, ... it has begun shipping Clobetasol Propionate Shampoo and ... ® Shampoo and Clobex ® Topical ... has granted Actavis a 180-day marketing exclusivity. ...

... Jan. 3, 2012 Cyberonics, Inc. (NASDAQ: CYBX ) ... (FDA) has approved its re-designed AspireHC (High Capacity) generator, which ... 2011. "We are pleased that the FDA was ... us to resume our limited commercial release of the AspireHC ...

Cached Medicine Technology:Actavis First-To-Market with Generic Equivalents of Clobex® Shampoo and Clobex® Topical Lotion 2 Cyberonics Announces FDA Approval of Re-Designed AspireHC™ Generator for VNS Therapy 2 Cyberonics Announces FDA Approval of Re-Designed AspireHC™ Generator for VNS Therapy 3

Actavis First-To-Market with Generic Equivalents of Clobex® Shampoo and Clobex® Topical Lotion Cyberonics Announces FDA Approval of Re-Designed AspireHC™ Generator for VNS Therapy

(Date:6/17/2013)... New York (PRWEB) June 18, 2013 ... has more physicians listed in New York magazine's ... In the latest survey, 209 NewYork-Presbyterian physicians from ... fortunate to have some of the nation's best ... J. Corwin, CEO of NewYork-Presbyterian Hospital. "We are ...

(Date:6/17/2013)... and Drug Administration (FDA) imposes new graphic warning ... First Amendment challenge if they depict health consequences ... evidence, says a Georgetown University Medical Center public ... warning labelswhich combine images with health warningsare a ... other countries, but the tobacco industry argues they ...

(Date:6/17/2013)... MA (PRWEB) June 17, 2013 Daimer ... robust steam cleaner equipment , such as expertly designed ... launched the KleenJet® Pro Plus 200S for apartment dwellers ... up to 310°F in 15 minutes and pressure levels ... effectively. The machine can be used to clean carpet ...

(Date:6/17/2013)... Bust’DD (pronounced ‘busted’), a new company that ... women with large busts, will soon launch their crowdfunding campaign ... understand the problem of ill-fitting bras and want to offer ... is to raise at least $25,000 to create their beta ... on a wide scale. , In order to kick off ...

(Date:6/17/2013)... (PRWEB) June 17, 2013 Today, ... stand-alone HRAs for small businesses . Zane Benefits, ... employer sponsored health benefits, is the leader in ... arrangements . , According to Zane Benefits’ website, ... Accounts or HRAs, offer small businesses an affordable ...

Breaking Medicine News(10 mins):Health News:NewYork-Presbyterian Leads NY Metro Area Hospitals on New York Magazine's Annual ‘Best Doctors' List 2 Health News:Can new FDA graphic warning labels for tobacco pass a first amendment legal challenge? 2 Health News:Daimer Ships Vapor Steam Cleaner For Homeowners 2 Health News:Daimer Ships Vapor Steam Cleaner For Homeowners 3 Health News:Arizona Startup Bust’DD Looking to Start a BRAvolution 2 Health News:Arizona Startup Bust’DD Looking to Start a BRAvolution 3 Health News:Zane Benefits Publishes New Information on Stand-Alone HRAs for Small Businesses 2

[0] NewYork-Presbyterian Leads NY Metro Area Hospitals on New York Magazine's Annual ‘Best Doctors' List [0] Can new FDA graphic warning labels for tobacco pass a first amendment legal challenge?[0] Daimer Ships Vapor Steam Cleaner For Homeowners [0] Arizona Startup Bust’DD Looking to Start a BRAvolution [0] Zane Benefits Publishes New Information on Stand-Alone HRAs for Small Businesses

... , , , ... , the global leader in thin computing and client virtualization, today announced ... Smiles is a rapidly-growing company whose mission is to bring quality dental ... first office in 2002 in Atlanta, GA, the network has demonstrated substantial ...

... , , , ... Health, Inc. (Nasdaq: GHDX ) today announced that Kim ... Adams 29th Annual Global Growth Conference in Boston, on Thursday, August ... access the live and subsequently archived webcast of the presentation, visit ...

... , , , ... Aug. 6 CSC (NYSE: CSC ... company as a preferred provider to help member hospitals comply with the ... U.S. federal government stimulus package. Under the ARRA, hospitals will receive incentive ...

... TAMPA, Fla., Aug. 6 Gold Standard/Elsevier ... of three MedCounselor consumer drug information modules for pharmacies and ... to take medications safely, assists in identifying unknown tablets or ... indispensable in helping to increase consumer compliance to their drug ...

... , KIBBUTZ SHAMIR, Israel, Aug. 6 Shamir ... to issue its second quarter of 2009 earnings results on Thursday, August ... at 11:00 A.M. EDT that morning. , , ... listen live, please go to www.kcsa.com approximately five ...

... Va., Aug. 6 Sunrise Senior Living, Inc. (NYSE: ... second quarter of 2009. Sunrise will host a conference call ... discuss the financial results. , , "Our restructuring ... expense controls. In recent weeks we have seen a modest lift ...

Kool Smiles Relies on Wyse Technology Virtual Clients to Improve Patient Care and Security of Electronic Health Records (EHRs)Genomic Health to Present at Canaccord Adams 29th Annual Global Growth Conference CSC to Help Georgia Hospital Association Members Achieve 'Meaningful Use' of Electronic Health Records Gold Standard/Elsevier Launches MedCounselor Consumer Drug Information Modules Shamir Optical Industry Ltd. to Host Conference Call Announcing Second Quarter of 2009 Earnings Results Sunrise Reports Financial Results for Second-Quarter 2009

... to order tips. Each box contains 10,000 ... available in easy-to-open, re-sealable Bulk Packs of ... sealed with a tamper-proof strip which can ... Gilsons Diamond Tips. Bulk Packs are closed ...

200 L, Bulk, yellow Recommended for 20, 25, 50, 100 and 200 L pipettes. Can also be used with 300 L pipettes when pipetting 200 L or less....

... the Finntip Wide is designed especially for ... genomic DNA. This tip eliminates the mechanical ... excellent for use with extremely viscous liquids. ... of the orifice is 1.1 mm or ...

Capillary section fits into a 0.3-mm well for accurate loading of sequencing gels...

Medicine Products:

EcoPack D200 200 L Pipette Tip Finntip 250 Wide StrataTips Pipet Tips, Flat (1-200 l)